Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

GlaxoSmithKline patents PI3K inhibitors

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

Sunshine Lake Pharma initiates phase I trial of litapiprant

Nov. 8, 2018

CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia

Nov. 7, 2018

VX-659/tezacaftor/ivacaftor triple combination regimen shows safety and efficacy in phase II study

Nov. 6, 2018

European Commission approves Symkevi in cystic fibrosis

Nov. 5, 2018

Galapagos initiates phase II PINTA trial of GLPG-1205 in IPF

Nov. 2, 2018

Galapagos reports Part 1 interim results from FALCON trial of cystic fibrosis combination treatment

Oct. 26, 2018

Santhera begins phase Ib/IIa study of POL-6014 in cystic fibrosis

Oct. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...